A Randomized Pilot Study Evaluating Combination Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Plus Metformin Compared to Metformin Monotherapy and Placebo on Metabolic Abnormalities in Women With a Recent History of GDM
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Metformin/sitagliptin (Primary) ; Metformin
- Indications Gestational diabetes
- Focus Biomarker; Therapeutic Use
- 29 Aug 2017 Planned End Date changed from 1 Feb 2018 to 1 Oct 2017.
- 29 Aug 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2017.
- 13 Jun 2017 Primary endpoint has been met. (Surrogate measures of insulin sensitivity and secretion), according to results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.